Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages

Abdellatif Bouazzaoui1, Marina Kreutz, Veronika Eisert

  • 1Georg-Speyer-Haus, Institute for Biomedical Research, 60596 Frankfurt/M., Germany.

Virology
|August 24, 2006
PubMed

Insights

Stimulated Trans-Acting Factor of 50 kDa (Staf50) gene overexpression inhibits HIV-1 replication in macrophages. This host factor plays a key role in controlling viral infection, suggesting potential therapeutic targets for HIV.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Monocyte-derived macrophages (MAC) are key targets for HIV-1 infection.
  • Cellular genes can influence HIV-1 replication.
  • Interferon (IFN) and lipopolysaccharide (LPS) stimulation inhibit HIV-1 in MAC.

Purpose of the Study:

  • Identify cellular genes that interfere with HIV-1 replication in MAC.
  • Investigate the role of Stimulated Trans-Acting Factor of 50 kDa (Staf50) in HIV-1 infection.

Main Methods:

  • Microarray analysis to identify differentially expressed genes.
  • Real-time PCR to quantify Staf50 expression.
  • Viral transduction for stable Staf50 overexpression in 293 T and MAC cells.
  • HIV-1 infection assays and p24 ELISA for viral replication monitoring.

Main Results:

  • Staf50 was identified as a gene overexpressed in IFN- and LPS-stimulated MAC, and in HIV-1 infected cells.
  • Stable overexpression of Staf50 significantly inhibited HIV-1 replication (50-90%) in both 293 T CD4/CCR5 cells and primary MAC.
  • Staf50 represses the activity of the HIV-1 Long Terminal Repeat (LTR).

Conclusions:

  • Host genetic factors, like Staf50, significantly impact HIV-1 replication.
  • Staf50 overexpression demonstrates potent antiviral activity against HIV-1.
  • Findings suggest Staf50 as a potential therapeutic target for controlling HIV-1 infection.